Diabetes: Progress and Promise in Stem Cell Research
CIRM has funded the Diabetes Disease Team led by scientists at ViaCyte, Inc., UCSF, and the La Jolla Institute for Allergy and Immunology. This team aims to bring an embryonic…
CIRM has funded the Diabetes Disease Team led by scientists at ViaCyte, Inc., UCSF, and the La Jolla Institute for Allergy and Immunology. This team aims to bring an embryonic…
Eugene Brandon speaks at the 2011 CIRM Grantee Meeting about Viacyte's efforts to develop a stem cell based treatment for diabetes. CIRM has awarded Viacyte $26 million to support their…
Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is the former president and CEO of…
Robert Klein, J.D. gave the welcoming remarks for the "Spotlight on Juvenile Diabetes", an educational event presented at the CIRM Governing Board meeting on September 25, 2008. Klein is Chair…
Ed Baetge, Ph.D. spoke at the Spotlight on Juvenile Diabetes, an educational event presented at the CIRM Governing Board meeting on September 25, 2008. Baetge discussed Novocell, Inc.'s (now…
Peter Butler, M.D. spoke at the Spotlight on Juvenile Diabetes, an educational event presented at the CIRM Governing Board meeting on September 25, 2008. Butler summarized normal glucose metabolism, explained…
Joelle Johnson spoke at the Spotlight on Juvenile Diabetes, an educational event presented at the CIRM Governing Board Meeting on September 25, 2008. Johnson talked about her diabetes diagnosis…
Alan Lewis, Ph.D., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. At the time of this presentation Alan Lewis…